The National Times - US plaintiff decries harmful social media addiction

US plaintiff decries harmful social media addiction


US plaintiff decries harmful social media addiction
US plaintiff decries harmful social media addiction / Photo: © GETTY IMAGES NORTH AMERICA/AFP

The plaintiff in a blockbuster social media trial in Los Angeles took the stand Thursday, telling the jury that she could not control her use of YouTube and Instagram as a child.

Change text size:

Kaley G.M., a 20-year-old California resident, painted a dire picture of a social media addiction that began when she was six years old and that she says exacerbated her mental health issues, including depression, body image problems and acts of self-harm.

"I was at a young age and I would spend all my time on it," Kaley testified when asked to explain why she thought she was addicted to YouTube. "Anytime I tried to separate myself from it, it just didn't work."

Even when she was bullied on Instagram, she still stayed on the app. "If I was off, I would just feel like I was missing out."

The landmark trial is expected to last until late March, when the jury will decide whether Meta, which owns Instagram, and Google-owned YouTube knowingly designed addictive apps that harmed her mental health.

Meta CEO Mark Zuckerberg took the stand last week and pushed back against accusations that his social media company had done too little to keep underage users off his platform and had profited from their presence.

In the highly anticipated testimony, Kaley took questions from her lawyer, who sought to portray her as an emotionally fragile user who was ensnared as a child by YouTube and Instagram and whose use of those apps caused her lasting harm.

"I'm very nervous," Kaley, wearing a pale pink cardigan, said as she began her testimony, which will include cross-examination by lawyers from Meta and Google.

Kaley described scenes from her childhood in which her mother would have her leave her phone in the living room at night, only for her to retrieve it once her mom went to bed and return it before morning.

"I would be really upset," she said, when denied access to the apps.

Her lawyer Mark Lanier said court records indicate that on one day she was on Instagram for 16 hours.

She said her mother pushed her into therapy at around age 12, and that during the first session she said she could not engage with her family at home because of "excessive worrying because of social media."

"I stopped engaging with them as much because I was spending all my time on social media," she recalled.

She also described her heavy use of filters on Instagram from a young age to make her eyes bigger and her ears smaller. The jury was shown a video in which she complained about being fat.

Shown a banner featuring dozens of her Instagram pictures, Kaley said "almost all of them have a filter on."

When asked if her life, health, sleep and grades would have been better without social media, Kaley answered: "Yes."

- Seeking job in social media -

In a surprising twist, Kaley said she would like to become a social media manager and capitalize on the skills she has built since a young age.

Kaley G.M.'s case is the first of three trials expected in the same court that will help determine whether Google and Meta deliberately designed their platforms to encourage compulsive use among young people, damaging their mental health in the process.

The outcome of the Los Angeles trials is expected to establish a standard for resolving thousands of lawsuits that blame social media for fueling an epidemic of depression, anxiety, eating disorders and suicide among young people.

Similar lawsuits, including some brought by school districts, are making their way through federal court in Northern California and state courts across the country.

S.Clarke--TNT

Featured

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets

CapTLX, the securities trading and investment platform operated by CHAINLION TECH LTD, today announced the continued expansion of its technology infrastructure for qualified investors and institutional market participants seeking structured access to U.S. equity and private capital markets.

Change text size: